Back to mobile site

More on CMND

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (12/15/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Clearmind Medicine (NQ:CMND)
Delayed: 0.80 -0.06 (6.98%)
Prev. Close $0.86  
Open$0.85 
52 Wk High$ 
52 Wk Low$ 
Day High$0.86 
Day Low$0.77 
P/E N/A  
EPS$ 
Volume194,696 

Friends, Peers and Foes (?): CWY0, SPRC, PLRZ, NTLX, IMCC (more...)

Sep 17, 2026 04:00 PM Form 6-K Clearmind Medicine Inc. For: Sep 17
Sep 17, 2026 07:44 AM Clearmind Medicine testifies at FDA psychedelic hearing in D.C.
Sep 17, 2026 07:42 AM Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
Sep 14, 2026 06:09 AM Form 6-K Clearmind Medicine Inc. For: Sep 14
Sep 11, 2026 08:01 AM Clearmind enrolls first AUD patients in CMND-100 trial
Sep 11, 2026 08:00 AM Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
Sep 10, 2026 04:06 PM Form 6-K Clearmind Medicine Inc. For: Jul 31
Sep 8, 2026 07:43 AM Yale approves Clearmind Medicine patient recruitment for CMND-100 trial
Sep 8, 2026 07:42 AM Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
Sep 4, 2026 07:32 AM Clearmind Medicine to acquire 51% of EV wireless charging firm
View All Articles

Entities mentioned with CMND

View All Entities